In this episode of Conversations in Lung Cancer Research, Dr. Malinda Itchins, Dr. Annie Wong, and A/Prof Stephen Kao discuss the concept of liquid biopsy, its advantages and limitations, and its clinical applications in lung cancer treatment. They explore how liquid biopsy can provide faster diagnosis and treatment options, especially for patients who cannot undergo traditional tissue biopsies. However, they also address the challenges of sensitivity and the need for further research to integrate liquid biopsy into routine clinical practice.

This episode is sponsored by: 

• AstraZeneca  
• Daiichi Sankyo Australia  
• SOPHiA Genetics  
• Thermo Fisher Scientific

(00:00) Introduction and Acknowledgements

(01:16) Meet the Experts

(02:10) Understanding Liquid Biopsy

(03:01) Advantages of Liquid Biopsy

(06:21) Limitations of Liquid Biopsy

(09:15) Clinical Scenarios for Liquid Biopsy

(13:15) Barriers and Future Directions

(19:39) Conclusion and Thank You